The Seattle Mariners’ search for a right-handed bat just got a lot harder.
Casey Schmitt, who had emerged as one of the cleaner trade possibilities on the market, left the San Francisco Giants’ game against the Milwaukee Brewers on Monday after appearing to injure himself rounding first base. He exited with left knee discomfort, and manager Tony Vitello said Schmitt was “doing all right,” with an MRI scheduled for Tuesday. Even so, Vitello later added that Schmitt “is probably going to miss some significant time."
The replay told the story. Schmitt’s legs buckled on the play, and when he walked off, he was limping. For a Mariners team already trying to patch together answers ahead of the trade deadline, that’s another hit to a shrinking pool of options.
Schmitt had become a logical target after injuries to Matt Shaw and Spencer Steer complicated the market. Shaw and Steer are not officially unavailable, but both are expected to remain sidelined beyond August 3.
Schmitt looked like the next name up. Now he may be off the board too.
That matters because Schmitt wasn’t just another bat. The 27-year-old was in the middle of a breakout season, setting career highs in batting average, slugging percentage, OPS and home runs. He also offered versatility in the field, and his right-handed bat had been especially effective against lefties, producing a .314 average and 123 RC+.
But even if the MRI brings better news than the field reaction suggested, the Mariners have to think twice. A player dealing with a knee issue is a risky bet, especially for a club that has already spent much of 2026 watching guys try to play through pain with disappointing results.
The market isn’t helping, either. The Curtis Mead trade between the Boston Red Sox and Washington Nationals pushed the price landscape for right-handed hitters in a direction that favored sellers. Once that deal happened, the chance of Seattle landing a good value on a righty bat seemed to vanish.
So Jerry Dipoto may need to get creative. Taylor Ward feels more like a rental than a solution.
Jo Adell and Heliot Ramos at least bring youth, control and real power, which gives them a different kind of appeal. Beyond that, the names get bigger and the odds get longer: George Springer, Matt Chapman, Willy Adames and Luis Robert Jr. are all there, but those are more dream scenarios than realistic fixes.
Seattle could also change the shape of its deadline entirely. A heavy pitching move, with Mason Miller as the centerpiece, is one possibility.
Another is a buy-and-sell approach that clears the way for younger players in August and September. Recent reporting makes it easy to picture Emerson Hancock and/or Luis Castillo moving out, with Kade Anderson, Ryan Sloan, Michael Arroyo and Lazaro Montes coming in.
For now, though, the most important thing is what the Mariners do not do: stand still. That’s the one outcome that looks truly dangerous. And with the way this season has gone, even that no longer feels like the most shocking possibility.
In Other News...
Mariners Make Another Bullpen Change After Crucial Win
After snapping a four-game skid with a 6-4 win over the Rangers, the Mariners are making another adjustment to the bullpen mix. Seattle recalled reliever Alex Hoppe from Triple-A Tacoma and sent Nick Davila back down, a move that comes on the heels of a much-needed victory powered by Dominic Canzones three-run homer and with George Kirby lined up to face Kumar Rocker in the next game.
For a club trying to steady itself after a rough stretch, these are the kinds of roster shuffles that can matter almost as much as the box score. The Mariners are still managing the usual late-season churn around the pitching staff, and with Brendan Donovan undergoing a medical evaluation before his return to the lineup, the broader picture around the roster remains unsettled even after the win that stopped the bleeding. [Read more 🡒]
Mets May Have An Exit Path From Costly Jorge Polanco Gamble
Jorge Polancos first season with the Mets has gone about as poorly as the club could have feared when it committed two years and $40 million to a player shifting to first base with limited experience there. Injuries have been part of the story from the start, and the offense has not offered much relief, with Polanco hitting .149 in 25 games and managing just one home run while trying to settle into a new role.
The Mets are now at least exploring ways to get out from under that gamble, and the conversation has naturally turned to whether there is any market at all for a player with this kind of contract and this kind of health record. Polancos recent stretch has only made that harder to sort out, leaving New York with a difficult decision and rival clubs weighing whether the upside is worth the risk. [Read more 🡒]
Mariners May Finally Break Their Pitching Blueprint At The Deadline
The Mariners have spent years building around run prevention, and that identity is now colliding with the realities of a deadline push. Seattle is still looking to add a right-handed bat and a reliever, but the more intriguing part of the conversation is on the pitching side, where the front office is at least considering a departure from its usual formula in order to make the roster better right now.
Luis Castillo and Emerson Hancock are both part of that discussion, even as George Kirby, Bryce Miller, Bryan Woo and Logan Gilbert are not expected to be moved. Castillos contract makes any deal more complicated, while Hancocks rise has given Seattle a different kind of trade chip to weigh. For a club that has long treated pitching as the safest path forward, the deadline could force a tougher kind of decision than usual. [Read more 🡒]